Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
685 studies found for:    "Cystic Fibrosis"
Show Display Options
Rank Status Study
21 Completed Multidose Safety and Tolerability Study of (Arikace™) for Inhalation In Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Intervention: Drug: Arikace™
22 Completed Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner
Condition: Cystic Fibrosis
Intervention:
23 Completed Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation
Condition: Cystic Fibrosis
Intervention:
24 Terminated Airway Secretion Clearance in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Device: High frequency chest wall oscillation;   Device: Oscillatory Positive Expiratory Pressure;   Other: PD&P: Postural drainage and percussion
25 Completed Inhaled Bicarbonate Therapy in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Procedure: inhaled sodium bicarbonate
26 Terminated Oxygen Therapy in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Other: Air - oxygen;   Other: Oxygen - Air
27 Completed
Has Results
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Condition: Cystic Fibrosis
Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID);   Drug: Placebo two times a day (BID)/three times a day (TID)
28 Completed PTC124 for Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: PTC124
29 Completed
Has Results
International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Condition: Cystic Fibrosis
Interventions: Drug: AZLI 75 mg three times a day (TID);   Drug: Placebo three times a day (TID)
30 Completed
Has Results
Absorptive Clearance in the Cystic Fibrosis Airway
Condition: Cystic Fibrosis
Intervention: Other: Technetium [Tc-99m] sulfur colloid and Indium [In-111] DTPA
31 Not yet recruiting Cystic Fibrosis (CF) Exacerbation and Insulin Treatment
Conditions: Cystic Fibrosis;   Impaired Glucose Tolerance;   Pulmonary Exacerbation
Interventions: Drug: novorapid / humalog short acting insulin;   Drug: Novo Rapid Insulin (Novonordisk)
32 Completed Volatile Organic Compounds in Cystic Fibrosis
Conditions: Cystic Fibrosis;   Pseudomonas Aeruginosa
Intervention: Other: Cystic Fibrosis patients
33 Completed Choline Nutrition in Children With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Dietary Supplement: Vitamin: Choline Bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1
34 Completed Benefits and Risks of Newborn Screening for Cystic Fibrosis
Conditions: Cystic Fibrosis;   Lung Disease;   Pseudomonas Infections
Intervention: Procedure: CF newborn screening
35 Active, not recruiting Imaging Airway Liquid Absorption in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Other: Absorptive clearance scan
36 Completed Infant Study of Inhaled Saline in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: 7% Hypertonic Saline (HS);   Drug: 0.9% Isotonic Saline (IS)
37 Terminated Sitagliptin in Cystic Fibrosis-Related Diabetes
Condition: Cystic Fibrosis
Interventions: Drug: Sitagliptin;   Drug: Placebo
38 Completed Antimicrobial Resistance in Cystic Fibrosis (CF)
Condition: Cystic Fibrosis
Intervention:
39 Completed Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis
Conditions: Cystic Fibrosis Related Diabetes;   Pancreatic Insufficiency
Interventions: Drug: placebo;   Drug: repaglinide
40 Unknown  Costimulatory Molecules as Biomarkers in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years